Fractyl Health 

$0.7226
50
-$0.08-9.79% Tuesday 20:00
+$0.02+3.35%Tuesday 23:59After hours

Statistics

Day High
0.734
Day Low
0.7227
52W High
2.45
52W Low
0.377
Volume
50,779
Avg. Volume
-
Mkt Cap
114.64M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

19AugExpected
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Next
-0.71
-0.45
-0.2
0.06
Expected EPS
-0.135
Actual EPS
N/A

Financials

-Profit Margin
Unprofitable
2022
2023
2024
2025
0Revenue
-140.95MNet Income

Analyst Ratings

5.50Average Price Target
The highest estimate is 8.00.
From 4 ratings within the last 6 months. This is not an investment recommendation.
Buy
75%
Hold
25%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow GUTS. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Medtronic
MDT
Mkt Cap107.36B
Medtronic offers products for the diagnosis and treatment of diabetes, competing in the broader metabolic health space.
Abbott Laboratories
ABT
Mkt Cap163.61B
Abbott Laboratories provides a wide range of medical devices, including those for diabetes care, directly competing in the metabolic health sector.
Dexcom
DXCM
Mkt Cap28.93B
DexCom, Inc. specializes in glucose monitoring systems for diabetes management, competing in the diabetes care market.
Insulet
PODD
Mkt Cap11.17B
Insulet Corporation offers innovative insulin delivery systems, competing in diabetes management and care.
Tandem Diabetes Care
TNDM
Mkt Cap1.06B
Tandem Diabetes Care, Inc. designs and manufactures insulin pumps, directly competing in the diabetes management space.
Mannkind
MNKD
Mkt Cap1.26B
MannKind Corporation focuses on inhaled therapeutic products for diabetes, offering alternative diabetes management solutions.
Novo Nordisk
NVO
Mkt Cap218.94B
Novo Nordisk is a leading global healthcare company that focuses on diabetes care products, insulin, and devices.
Sanofi
SNY
Mkt Cap104.13B
Sanofi provides a broad range of insulin and diabetes management solutions, competing in the global diabetes care market.
Merck
MRK
Mkt Cap305.12B
Merck & Co., Inc. offers pharmaceutical products for the treatment of diabetes, competing in the medication aspect of diabetes care.
Bristol-Myers Squibb
BMY
Mkt Cap117.58B
Bristol-Myers Squibb Company engages in the discovery, development, and delivery of medicines for diabetes, among other areas.

About

Fractyl Health, Inc., a metabolic therapeutics company, develops therapies for the treatment of type 2 diabetes (T2D) and obesity. The company develops Revita DMR System (Revita), an outpatient procedural therapy designed to durably modify duodenal dysfunction, a pathologic consequence of a high fat and high sugar diet, which can initiate T2D and obesity in humans. It develops Rejuva, a novel adeno-associated virus delivered pancreatic gene therapy platform that is designed to enable long-term remission of T2D and obesity by durably altering metabolic hormone function in the pancreatic islet cells of patients. Fractyl Health, Inc. was formerly known as Fractyl Laboratories Inc. and changed its name to Fractyl Health, Inc. on June 09, 2021. The company was incorporated in 2010 and is headquartered in Burlington, Massachusetts.
Show more...
CEO
Dr. Harith Rajagopalan M.D., Ph.D.
Employees
100
Country
United States
ISIN
US35168W1036

Listings

0 Comments

Share your thoughts

FAQ

What is Fractyl Health stock price today?
The current price of GUTS is $0.72 USD — it has decreased by -9.79% in the past 24 hours. Watch Fractyl Health stock price performance more closely on the chart.
What is Fractyl Health stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Fractyl Health stocks are traded under the ticker GUTS.
Is Fractyl Health stock price growing?
GUTS stock has fallen by -4.67% compared to the previous week, the month change is a -9.18% fall, over the last year Fractyl Health has showed a -60.3% decrease.
What is Fractyl Health market cap?
Today Fractyl Health has the market capitalization of 114.64M
When is the next Fractyl Health earnings date?
Fractyl Health is going to release the next earnings report on August 19, 2026.
What were Fractyl Health earnings last quarter?
GUTS earnings for the last quarter are 0.06 USD per share, whereas the estimation was -0.16 USD resulting in a +137.5% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Fractyl Health revenue for the last year?
Fractyl Health revenue for the last year amounts to 0 USD.
What is Fractyl Health net income for the last year?
GUTS net income for the last year is -140.95M USD.
How many employees does Fractyl Health have?
As of July 29, 2026, the company has 100 employees.
In which sector is Fractyl Health located?
Fractyl Health operates in the Health & Wellness sector.
When did Fractyl Health complete a stock split?
Fractyl Health has not had any recent stock splits.
Where is Fractyl Health headquartered?
Fractyl Health is headquartered in Burlington, United States.